Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase
| Image |  |
|---|---|
| Description | scientific article published on 15 March 2013 |
| Author/s |
author: Albert Hoenekopp Matt E Kalaycio Gianantonio Rosti Hagop Kantarjian Carmino Antônio de Souza Yaping Shou Richard A. Larson Giuseppe Saglio Andreas Hochhaus |
| Publication date | March 15, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |